MX2008001034A - Nuevos derivados de pirido[3',2':4,5]furo[3,2-d]pirimidina. - Google Patents
Nuevos derivados de pirido[3',2':4,5]furo[3,2-d]pirimidina.Info
- Publication number
- MX2008001034A MX2008001034A MX2008001034A MX2008001034A MX2008001034A MX 2008001034 A MX2008001034 A MX 2008001034A MX 2008001034 A MX2008001034 A MX 2008001034A MX 2008001034 A MX2008001034 A MX 2008001034A MX 2008001034 A MX2008001034 A MX 2008001034A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- sub
- alkyl
- group
- groups
- Prior art date
Links
- DCVNVQFCEXGISL-UHFFFAOYSA-N pyrido[4,5]furo[1,2-b]pyrimidine Chemical class N1=CN=C2C3=CC=CN=C3OC2=C1 DCVNVQFCEXGISL-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- -1 amino, hydroxy Chemical group 0.000 abstract 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invencion da a conocer un derivado de piridofuropirimidina de formula (I) (ver formula (I)): en la que: G1 representa un grupo seleccionado de -CR6R7- y -O- en el que R6 y R7 representan independientemente atomos de hidrogeno o grupos alquilo C1-4; R1 y R2 se seleccionan independientemente de atomos de hidrogeno y grupos alquilo C1-4; R3 representa un grupo seleccionado de alquilo C1-4, alcoxi C1-4, amino, hidroxi, monoalquil C1-4-amino, dialquil C1-4-amino, cicloalquil C3-8-amino, arilo, heteroarilo y grupos heterociclicos que contienen N saturados que estan unidos al anillo de piridina a traves de su atomo de nitrogeno, estando todos ellos opcionalmente sustituidos con uno o mas sustituyentes seleccionados del grupo constituido por atomos de halogeno y grupos hidroxi, alquilo C1-4, alcoxi C1-4-alquilo C1-4, arilalquilo C1-4, -O(CO)O R8, alcoxi C1-4, -(CO)NR8R9, -CN, -CF3, -NR8R9, -SR8 y -SO2NH2, representando independientemente cada R8 y R9 un atomo de hidrogeno o un grupo alquilo C1-4; R4 y R5 se seleccionan independientemente del grupo constituido por atomos de hidrogeno, grupos alquilo C1-4, grupos hidroxialquilo C1-4 y grupos de formula (II) (ver formula (II)): en la que p y q son enteros seleccionados de 0, 1, 2 y 3; A es un enlace directo o un grupo seleccionado de -CONR14-, -NR14CO-, -O-, -COO-, -OCO-, -S-, -SO- y -SO2-, representado independientemente cada R10, R11, R12, R13 y R14 un atomo de hidrogeno o un grupo alquilo C1-4 y siendo G2 un grupo seleccionado de grupos arilo, heteroarilo, o heterociclilo; estando opcionalmente sustituido el grupo G2 con uno o mas sustituyentes seleccionados del grupo constituido por atomos de halogeno y grupos C1-4 alquilo, hidroxi, oxo, alcoxi C1-4-alquilo C1-4, arilalquilo C1-4, -(CO)OR16, alcoxi C1-4, -(CO)NR16R17, -CN, -CF3, -NR16R17, -SR16 y -SO2NH2; representando independientemente cada R16 y R17 un atomo de hidrogeno o un grupo alquilo C1-4, y las sales y N-oxidos farmaceuticamente aceptables de los mismos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200501840A ES2281251B1 (es) | 2005-07-27 | 2005-07-27 | Nuevos derivados de pirido (3',2':4,5) furo (3,2-d) pirimidina. |
| PCT/EP2006/007218 WO2007017078A1 (en) | 2005-07-27 | 2006-07-21 | NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008001034A true MX2008001034A (es) | 2008-03-14 |
Family
ID=36121512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008001034A MX2008001034A (es) | 2005-07-27 | 2006-07-21 | Nuevos derivados de pirido[3',2':4,5]furo[3,2-d]pirimidina. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20080221096A1 (es) |
| EP (1) | EP1913003A1 (es) |
| JP (1) | JP2009502832A (es) |
| KR (1) | KR20080039384A (es) |
| CN (1) | CN101263144A (es) |
| AR (1) | AR055999A1 (es) |
| AU (1) | AU2006278857A1 (es) |
| CA (1) | CA2616424A1 (es) |
| EC (1) | ECSP088108A (es) |
| ES (1) | ES2281251B1 (es) |
| IL (1) | IL188724A0 (es) |
| MX (1) | MX2008001034A (es) |
| NO (1) | NO20081009L (es) |
| PE (1) | PE20070237A1 (es) |
| RU (1) | RU2008107030A (es) |
| TW (1) | TW200738730A (es) |
| WO (1) | WO2007017078A1 (es) |
| ZA (1) | ZA200800352B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2046753A2 (en) * | 2006-07-06 | 2009-04-15 | Brystol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| EP2226323A1 (en) * | 2009-02-27 | 2010-09-08 | Almirall, S.A. | New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives |
| CN102898432A (zh) * | 2011-07-29 | 2013-01-30 | 山东轩竹医药科技有限公司 | 三并环化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| CN1186324C (zh) * | 2000-04-27 | 2005-01-26 | 山之内制药株式会社 | 稠合杂芳基衍生物 |
| WO2002088079A2 (en) * | 2001-05-01 | 2002-11-07 | Bristol-Myers Squibb Company | Dual inhibitors of pde 7 and pde 4 |
| ES2259891B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
| ES2259892B1 (es) * | 2004-11-30 | 2007-11-01 | Laboratorios Almirall S.A. | Nuevos derivados de piridotienopirimidina. |
-
2005
- 2005-07-27 ES ES200501840A patent/ES2281251B1/es not_active Expired - Fee Related
-
2006
- 2006-07-21 WO PCT/EP2006/007218 patent/WO2007017078A1/en not_active Ceased
- 2006-07-21 KR KR1020087002113A patent/KR20080039384A/ko not_active Withdrawn
- 2006-07-21 MX MX2008001034A patent/MX2008001034A/es not_active Application Discontinuation
- 2006-07-21 CA CA002616424A patent/CA2616424A1/en not_active Abandoned
- 2006-07-21 US US11/996,781 patent/US20080221096A1/en not_active Abandoned
- 2006-07-21 RU RU2008107030/04A patent/RU2008107030A/ru not_active Application Discontinuation
- 2006-07-21 CN CNA2006800338219A patent/CN101263144A/zh active Pending
- 2006-07-21 JP JP2008523200A patent/JP2009502832A/ja active Pending
- 2006-07-21 EP EP06762762A patent/EP1913003A1/en not_active Withdrawn
- 2006-07-21 AU AU2006278857A patent/AU2006278857A1/en not_active Abandoned
- 2006-07-25 AR ARP060103191A patent/AR055999A1/es unknown
- 2006-07-25 PE PE2006000897A patent/PE20070237A1/es not_active Application Discontinuation
- 2006-07-27 TW TW095127490A patent/TW200738730A/zh unknown
-
2008
- 2008-01-10 IL IL188724A patent/IL188724A0/en unknown
- 2008-01-11 ZA ZA200800352A patent/ZA200800352B/xx unknown
- 2008-01-16 EC EC2008008108A patent/ECSP088108A/es unknown
- 2008-02-27 NO NO20081009A patent/NO20081009L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20081009L (no) | 2008-02-27 |
| ES2281251A1 (es) | 2007-09-16 |
| AU2006278857A1 (en) | 2007-02-15 |
| KR20080039384A (ko) | 2008-05-07 |
| RU2008107030A (ru) | 2009-09-10 |
| CA2616424A1 (en) | 2007-02-15 |
| JP2009502832A (ja) | 2009-01-29 |
| EP1913003A1 (en) | 2008-04-23 |
| TW200738730A (en) | 2007-10-16 |
| CN101263144A (zh) | 2008-09-10 |
| IL188724A0 (en) | 2008-08-07 |
| WO2007017078A1 (en) | 2007-02-15 |
| PE20070237A1 (es) | 2007-04-21 |
| ECSP088108A (es) | 2008-02-20 |
| ZA200800352B (en) | 2008-12-31 |
| US20080221096A1 (en) | 2008-09-11 |
| ES2281251B1 (es) | 2008-08-16 |
| AR055999A1 (es) | 2007-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20070328T3 (hr) | SUPSTITUIRANI 8'-PIRI(MI)DINILDIHIDROSPIRO[CIKLO-ALKLIAMIN]PIRIMIDO[1,2-a]PIRIMIDIN-6-ONSKI DERIVATI | |
| MA32249B1 (fr) | Dérivés polysubstitues de 2-heteroaryl-6-phenyl-imidazo[1,2- a]pyridines, leur préparation et leur application en thérapeutique | |
| ATE373656T1 (de) | Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
| PE20030808A1 (es) | Derivados triciclicos heterociclicos como antagonistas receptores de trombina | |
| EA201100975A1 (ru) | Производные 1,2,4-оксадиазола и их применение в терапии | |
| EA201490580A1 (ru) | Пирролбензодиазепины и их конъюгаты | |
| EA201071112A1 (ru) | ПРОИЗВОДНЫЕ ПОЛИЗАМЕЩЁННЫХ 2-АРИЛ-6-ФЕНИЛИМИДАЗО[1,2-a]ПИРИДИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ ИХ В ТЕРАПИИ | |
| MY143370A (en) | Fused quinoline derivative and use thereof | |
| NO20073283L (no) | Nye pyridotienopyrimidinderivater | |
| PE20130012A1 (es) | Derivados de pirazol como inhibidores de jak | |
| CY1112997T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΙΜΙΔΑΖΟ[1,5-α]ΠΥΡΙΔΙΝΩΝ, Η ΔΙΑΔΙΚΑΣIΑ ΠΑΡΑΣΚΕΥΗΣ ΤΟΥΣ ΚΑΙ ΟΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΑ ΠΕΡΙΕΧΟΥΝ | |
| RU2010125902A (ru) | Способ получения замещенных гетероциклом производных пиридина | |
| UY25344A1 (es) | Procedimiento para la preparacion de derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos | |
| CY1113549T1 (el) | Πολυυποκατεστημενα παραγωγα των 2-αρυλο-6-φαινυλ-ιμιδαζο[1,2-α]πυριδινων, η παρασκευη τους και η θεραπευτικη εφαρμογη τους | |
| PE20060185A1 (es) | ANTAGONISTA DEL RECEPTOR A2A DE LA ADENOSINA CON ESTRUCTURA DE PIRAZOLO--[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA | |
| WO2020184670A1 (ja) | 二級アミンを含有する化合物のアミン部分に重水素低級アルキルを導入する方法 | |
| NO20073271L (no) | Nye pyridotienopyrimidinderivater | |
| Sirakanyan et al. | New heterocyclic systems derived from pyridine: new substrates for the investigation of the azide/tetrazole equilibrium | |
| BRPI0611455A2 (pt) | diaril-purinas, azapurinas e deazapurinas como inibidores não nucleosìdicos da transcriptase reversa para tratamento de hiv | |
| MX2008001034A (es) | Nuevos derivados de pirido[3',2':4,5]furo[3,2-d]pirimidina. | |
| AR041689A1 (es) | Derivados de piridoindolona substituidos en 3- por un fenilo su preparacion y su aplicacion en terapeutica | |
| ECSP066474A (es) | Arilindenopiridinas y arilindenopirimidinas y su uso como antagonista del receptor adenosina a2a | |
| YU58301A (sh) | 2-aminopiridini koji sadrže supstituente sa kondenzovanim prstenom | |
| CO6270222A2 (es) | Derivados de tiomuracin y su uso como antibioticos | |
| WO2021084264A1 (en) | Isoquinoline derivatives as sik2 inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |